ELIXA

Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide)

Stadium: klaar
Middel: lixisenatide
Populatie: Diabetes Mellitus
Fase: III
First Patient In: 15 augustus 2010
Last Patient In: 31 juli 2013
Last Patient Last Visit: -

Studiedirecteur

prof. dr. J.H. Cornel

Cardioloog